Clinical Trial Update: RELVAR Effects on Parasternal Muscle Activity, Diaphragm, and Ventilation in Severe COPD [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating RELVAR's effects on parasternal muscle activity, diaphragm function, and ventilation in adults with severe chronic obstructive pulmonar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• RELVAR (fluticasone furoate/vilanterol)

Snippet

Sponsor: University of Calgary | Conditions: Copd | Phase 4 | Status: ACTIVE_NOT_RECRUITING